Birgitte Preiss - Concepedia

Author

Birgitte Preiss

Also Known As

B. Preiss, B.S. Preiss, Birgitte Preiss, Birgitte S. Preiss, Birgitte Strange Preiss, C Schoellkopf, Preiss, B., Preiss, Birgitte S, Preiss, Birgitte S.

Publications

881

Citations

H-Index

Concepts

All Affiliations

Odense University Hospital Vejle Sygehus Aarhus University Hospital Herlev Hospital Rigshospitalet

About

Birgitte Preiss is an author at Odense University Hospital specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	209
2	Cell Biology	3	3	56
3	Health Sciences	2	2	79
4	Public Health	1	1	13
5	Cellular Therapies	1	1	26

Birgitte Preiss

Publications

798

Citations

H-Index

Page 1

	Year	Citations
Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study Lene Sofie Granfeldt Østgård, Bruno C. Medeiros, Henrik Sengeløv, Journal of Clinical Oncology	2015	436
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population Rasmus Sørrig, Tobias Wirenfeldt Klausen, Morten Salomo, PLoS ONE	2017	51
Proteasome inhibitors and <scp>IM</scp>iDs can overcome some high‐risk cytogenetics in multiple myeloma but not gain 1q21 Hareth Nahi, Thea Kristin Våtsveen, Johan Lund, European Journal Of Haematology Proteasome InhibitorsMixed-phenotype Acute LeukemiaImmunologyHigh‐risk CytogeneticsPathology	2015	40
NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression* Thomas Kielsgaard Kristensen, Michael Møller, Lone Smidstrup Friis, European Journal Of Haematology Npm1 MutationMixed-phenotype Acute LeukemiaGeneticsPathologyStable Marker	2011	39
Cytogenetic findings in adult <i>de novo</i> acute myeloid leukaemia. A population‐based study of 303/337 patients Birgitte Preiss, Gitte Kerndrup, Kai Gjerløff Schmidt, British Journal of Haematology	2003	37
Clinicopathological features of plasmablastic multiple myeloma: a population‐based cohort Hanne Elisabeth Højsgaard Møller, Birgitte Preiss, Per Trøllund Pedersen, Apmis Hematological MalignancyMalignant Blood DisorderPlasmablastic MorphologySpectral KaryotypingMedicine	2015	31
Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML Birgitte Preiss, Olav J. Bergmann, Lone S. Friis, Cancer Genetics and Cytogenetics Hematological MalignancyChromatinMedicineGeneticsHematology	2010	30
Human cancer evolution in the context of a human immune system in mice Odd Lilleng Gammelgaard, Mikkel G. Terp, Birgitte Preiss, Molecular Oncology Cell TherapyCancer ModelHuman Immune SystemImmunologyBiological Microenvironments	2018	26
Upregulation of Syndecan‐1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis Niels Frost Andersen, Ida Bruun Kristensen, Birgitte Preiss, European Journal Of Haematology	2014	24
The real-world outcomes of multiple myeloma patients treated with daratumumab Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Mette Bøegh Levring, PLoS ONE	2021	23

Page 1